Acute myeloid leukemia: current progress and future directionsHagop M. Kantarjian, Farhad Ravandi|Blood Cancer Journal|2021Cited by 750
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working PartyMichael Heuser, Jacqueline Cloos, Sylvie Freeman et al.|Blood|2021Cited by 714
Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in OncologyMargaret O’Donnell, Ndiya Ogba, Martin S. Tallman et al.|Journal of the National Comprehensive Cancer Network|2017Cited by 655
Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNetMiguel Á. Sanz, Francesco Lo‐Coco, Pierre Fenaux et al.|Blood|2019Cited by 655
Phase 1/2 study of the combination of 5-aza-2′-deoxycytidine with valproic acid in patients with leukemiaGuillermo Garcia‐Manero, Jean‐Pierre J. Issa, Hagop M. Kantarjian et al.|Blood|2006Cited by 468